What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Pharmacology
Frank Porreca mainly focuses on Pharmacology, Neuropathic pain, Anesthesia, Opioid and Neuroscience.
Frank Porreca interconnects Agonist, Receptor, Antagonist and Cannabinoid receptor in the investigation of issues within Pharmacology.
His Neuropathic pain research incorporates themes from Nerve injury, Sensory system, Dorsal root ganglion and Allodynia.
His Anesthesia research includes elements of Naltrexone, Headaches, Rostral ventromedial medulla and Nociception.
His Opioid research entails a greater understanding of Internal medicine.
His work investigates the relationship between Neuroscience and topics such as Hyperalgesia that intersect with problems in Cholecystokinin, Inflammation and Capsaicin.
His most cited work include:
- Chronic pain and medullary descending facilitation (799 citations)
- Potent and nontoxic antisense oligonucleotides containing locked nucleic acids (656 citations)
- Central modulation of pain (628 citations)
What are the main themes of his work throughout his whole career to date?
Frank Porreca mainly investigates Pharmacology, Opioid, Receptor, Internal medicine and Endocrinology.
The various areas that Frank Porreca examines in his Pharmacology study include Agonist, Antagonist and Nociception.
His research on Opioid often connects related areas such as Hyperalgesia.
The Receptor study combines topics in areas such as Structure–activity relationship and Stereochemistry.
Frank Porreca is exploring Neuropathic pain as part of his Neuroscience and Anesthesia and Neuropathic pain studies.
His Anesthesia study combines topics in areas such as Calcitonin gene-related peptide and Rostral ventromedial medulla.
He most often published in these fields:
- Pharmacology (39.41%)
- Opioid (31.26%)
- Receptor (22.81%)
What were the highlights of his more recent work (between 2013-2021)?
- Pharmacology (39.41%)
- Opioid (31.26%)
- Neuroscience (17.04%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Pharmacology, Opioid, Neuroscience, Chronic pain and Neuropathic pain.
His research in Pharmacology intersects with topics in Agonist, Receptor, Antagonist, Dynorphin and Dynorphin A.
His biological study spans a wide range of topics, including Morphine, Central nucleus of the amygdala and Hyperalgesia, Rostral ventromedial medulla.
His study in Hyperalgesia is interdisciplinary in nature, drawing from both Endocrinology, Prolactin, Prolactin receptor and Nociceptor.
His studies in Neuroscience integrate themes in fields like μ-opioid receptor and Migraine.
Frank Porreca works mostly in the field of Neuropathic pain, limiting it down to topics relating to Nociception and, in certain cases, GABAA receptor.
Between 2013 and 2021, his most popular works were:
- Descending pain modulation and chronification of pain. (298 citations)
- Reward and motivation in pain and pain relief (248 citations)
- The ACTTION-American Pain Society Pain Taxonomy (AAPT): An Evidence-Based and Multidimensional Approach to Classifying Chronic Pain Conditions (105 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Gene
Frank Porreca mostly deals with Chronic pain, Neuroscience, Neuropathic pain, Anesthesia and Pharmacology.
The Chronic pain study combines topics in areas such as Nociception, Analgesic, Brain stimulation reward, Anxiety and Intensive care medicine.
His Neuroscience research includes themes of Hyperalgesia and Opioid.
His Neuropathic pain research is multidisciplinary, incorporating elements of Gabapentin, Duloxetine, Threshold of pain and Intrathecal.
His Anesthesia study incorporates themes from EGR1, Transcription factor, Gene expression and Calcitonin gene-related peptide.
His Pharmacology study frequently draws connections between adjacent fields such as Allodynia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
